Takeda Pharmaceutical Statistics
Total Valuation
TAK has a market cap or net worth of $42.15 billion. The enterprise value is $75.18 billion.
| Market Cap | 42.15B |
| Enterprise Value | 75.18B |
Important Dates
The next estimated earnings date is Thursday, July 25, 2024, before market open.
| Earnings Date | Jul 25, 2024 |
| Ex-Dividend Date | Mar 27, 2024 |
Share Statistics
TAK has 3.16 billion shares outstanding. The number of shares has increased by 1.20% in one year.
| Shares Outstanding | 3.16B |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.49% |
| Float | 1.55B |
Valuation Ratios
The trailing PE ratio is 46.07 and the forward PE ratio is 23.04. TAK's PEG ratio is 3.23.
| PE Ratio | 46.07 |
| Forward PE | 23.04 |
| PS Ratio | 1.50 |
| Forward PS | 0.01 |
| PB Ratio | 0.91 |
| P/FCF Ratio | 12.08 |
| PEG Ratio | 3.23 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.83, with an EV/FCF ratio of 21.55.
| EV / Earnings | 79.01 |
| EV / Sales | 2.67 |
| EV / EBITDA | 11.83 |
| EV / EBIT | 43.45 |
| EV / FCF | 21.55 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.78.
| Current Ratio | 1.11 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | 5.67 |
| Debt / FCF | 10.33 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is 2.10% and return on invested capital (ROIC) is 4.52%.
| Return on Equity (ROE) | 2.10% |
| Return on Assets (ROA) | 1.00% |
| Return on Capital (ROIC) | 4.52% |
| Revenue Per Employee | $571,462 |
| Profits Per Employee | $19,309 |
| Employee Count | 49,281 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.30 |
Taxes
| Income Tax | -580.37M |
| Effective Tax Rate | -156.35% |
Stock Price Statistics
The stock price has decreased by -13.47% in the last 52 weeks. The beta is 0.50, so TAK's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -13.47% |
| 50-Day Moving Average | 13.19 |
| 200-Day Moving Average | 13.93 |
| Relative Strength Index (RSI) | 53.83 |
| Average Volume (20 Days) | 1,781,049 |
Short Selling Information
| Short Interest | 7.13M |
| Short Previous Month | 6.57M |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.46% |
| Short Ratio (days to cover) | 5.74 |
Income Statement
In the last 12 months, TAK had revenue of $28.16 billion and earned $951.57 million in profits. Earnings per share was $0.29.
| Revenue | 28.16B |
| Gross Profit | 18.01B |
| Operating Income | 1.36B |
| Pretax Income | 334.37M |
| Net Income | 951.57M |
| EBITDA | 6.35B |
| EBIT | 1.73B |
| Earnings Per Share (EPS) | $0.29 |
Balance Sheet
The company has $3.00 billion in cash and $36.03 billion in debt, giving a net cash position of -$33.03 billion or -$10.47 per share.
| Cash & Cash Equivalents | 3.00B |
| Total Debt | 36.03B |
| Net Cash | -33.03B |
| Net Cash Per Share | -$10.47 |
| Equity (Book Value) | 46.18B |
| Book Value Per Share | 14.64 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was $4.55 billion and capital expenditures -$1.06 billion, giving a free cash flow of $3.49 billion.
| Operating Cash Flow | 4.55B |
| Capital Expenditures | -1.06B |
| Free Cash Flow | 3.49B |
| FCF Per Share | $1.11 |
Margins
Gross margin is 63.96%, with operating and profit margins of 4.83% and 3.38%.
| Gross Margin | 63.96% |
| Operating Margin | 4.83% |
| Pretax Margin | 1.19% |
| Profit Margin | 3.38% |
| EBITDA Margin | 22.56% |
| EBIT Margin | 6.14% |
| FCF Margin | 12.39% |
Dividends & Yields
This stock pays an annual dividend of $0.61, which amounts to a dividend yield of 4.58%.
| Dividend Per Share | $0.61 |
| Dividend Yield | 4.58% |
| Dividend Growth (YoY) | 0.02% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 210.91% |
| Buyback Yield | -1.20% |
| Shareholder Yield | 3.38% |
| Earnings Yield | 2.26% |
| FCF Yield | 8.28% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TAK has an Altman Z-Score of 1.01 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.01 |
| Piotroski F-Score | 6 |